Publication:
Interaction of epirubicin HCl with surfactants: Effect of NaCl and glucose

dc.contributor.authorÇAKIR, NEŞE
dc.contributor.authorGÖKTÜRK, SİNEM
dc.contributor.authorsErdinc, N; Gokturk, S; Tuncay, W
dc.date.accessioned2022-03-12T17:16:37Z
dc.date.accessioned2026-01-11T15:32:57Z
dc.date.available2022-03-12T17:16:37Z
dc.date.issued2004
dc.description.abstractThe interaction of an antitumoural drug, Epirubicin HCl, with anionic (sodiumdodecylsulfate; SDS), cationic (cetyltrimethylammonium bromide; CTAB), and nonionic (t-octylphenoxypolyethoxyethanol; TX-100, polyoxyethylenesorbitanmonolaurate; Tween 20) surfactants has been studied by absorption spectra as a function of surfactant concentration ranging from the premicellar to postmicellar region. At the concentrations below the critical micelle concentration (CMC), the equilibrium complex formation constant between Epirubicin cations and SDS anions has been determined by Job's method. Above the CMC, binding constant (K-b) of Epirubicin to various types of micelles has been calculated by means of the Benesi-Hildebrand Equation. The nonionic surfactant micelles showed stronger interaction than the ionic SDS micelles, and the binding tendency of Epirubicin followed the order: Tween 20 > TX-100 > SDS. Binding of Epirubicin also has been studied in the presence of NaCl and glucose because it is administered to patients intravenously in 0.9% NaCl or 5% glucose solution. The additives have been observed to affect the CMC of the surfactants and the Epirubicin-micelle binding constant appreciably. The presence of NaCl and glucose lowered the CMC of all the surfactants studied. The binding constant of Epirubicin decreased in the presence of NaCl but increased in the presence of glucose. The equilibrium complex formation constant between Epirubicin and SDS decreased in the presence of NaCl compared with purely aqueous media. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association.
dc.identifier.doi10.1002/jps.20056
dc.identifier.issn0022-3549
dc.identifier.pubmed15124214
dc.identifier.urihttps://hdl.handle.net/11424/227636
dc.identifier.wosWOS:000221808700018
dc.language.isoeng
dc.publisherJOHN WILEY & SONS INC
dc.relation.ispartofJOURNAL OF PHARMACEUTICAL SCIENCES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectinteraction
dc.subjectsurfactants
dc.subjectSDS
dc.subjectTX100
dc.subjectTween 20
dc.subjectEpirubicin HCl
dc.subjectbinding constant
dc.subjectNaCl
dc.subjectglucose
dc.subjectJob's method
dc.subjectPERFORMANCE LIQUID-CHROMATOGRAPHY
dc.subjectSODIUM DODECYL-SULFATE
dc.subjectIONIC MICELLES
dc.subjectABSORPTION-SPECTROSCOPY
dc.subjectPROTOTROPIC EQUILIBRIUM
dc.subjectELECTRONIC ABSORPTION
dc.subjectNONIONIC MICELLES
dc.subjectCACO-2 CELLS
dc.subjectFLUORESCENCE
dc.subjectBINDING
dc.titleInteraction of epirubicin HCl with surfactants: Effect of NaCl and glucose
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage1576
oaire.citation.issue6
oaire.citation.startPage1566
oaire.citation.titleJOURNAL OF PHARMACEUTICAL SCIENCES
oaire.citation.volume93

Files